You have 9 free searches left this month | to do more

umbralisib

Umbralisib is a drug used to treat Chronic Lymphocytic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, and other conditions. Umbralisib is being actively studied in 19 studies; no studies for this drug have been completed so far.

Top SponsorsTop SitesTop Investigators
TG Therapeutics, Inc.TG Therapeutics Investigational Trial SiteAmitkumar Mehta, MD
ADC Therapeutics S.A.Ohio State University Comprehensive Cancer CenterJacob Soumerai, MD
City of Hope Medical Center21st Century OncologyJennifer R. Brown, MD, PhD
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
  • Hodgkin's Lymphoma
  • Pembrolizumab
  • Umbralisib
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-08-23
Aug 23, 2021
U
Recruiting
  • Mantle Cell Lymphoma
  • Birmingham, Alabama
    University of Alabama at Birmingham
2021-09-08
Sep 8, 2021
U
Recruiting
  • Marginal Zone Lymphoma
  • Follicular Lymphoma
  • Aurora, Colorado
    University of Colorado Hospital
2021-02-19
Feb 19, 2021
W
Recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • New York, New York
    Weill Cornell Medicine
2021-03-19
Mar 19, 2021
T
Recruiting
  • Follicular Lymphoma
  • Small Lymphocytic Lymphoma
  • Fort Myers, Florida
  • +2 more
2021-11-11
Nov 11, 2021
T
Recruiting
  • Chronic Lymphocytic Leukemia
  • Non-Hodgkin Lymphoma
  • Chicago, Illinois
  • +2 more
2021-11-11
Nov 11, 2021
T
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Richter Syndrome
  • Umbralisib
  • +2 more
  • New York, New York
  • +3 more
2021-11-11
Nov 11, 2021
H
Recruiting
  • Chronic Lymphocytic Leukemia
  • Umbralisib
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
2021-11-15
Nov 15, 2021
C
Recruiting
  • Mantle Cell Lymphoma
  • Duarte, California
    City of Hope Medical Center
2021-08-10
Aug 10, 2021
M
Recruiting
  • Lymphoma
  • +6 more
  • Boston, Massachusetts
  • +1 more
2020-08-31
Aug 31, 2020
T
Active, not recruiting
  • Waldenstrom Macroglobulinemia
  • Umbralisib
  • Washington, District of Columbia
  • +3 more
2021-11-11
Nov 11, 2021
Y
Recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +23 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
2021-11-29
Nov 29, 2021
J
Recruiting
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Boston, Massachusetts
  • +2 more
2021-05-10
May 10, 2021
T
Recruiting
  • Non Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • East Melbourne, Victoria, Australia
  • +7 more
2021-11-11
Nov 11, 2021
T
Active, not recruiting
  • Diffuse Large B-Cell Lymphoma
  • +4 more
  • Ublituximab
  • +2 more
  • Birmingham, Alabama
  • +167 more
2021-11-11
Nov 11, 2021
N
Recruiting
  • Grade 1 Follicular Lymphoma
  • +4 more
  • Bendamustine Hydrochloride
  • +7 more
  • Anchorage, Alaska
  • +422 more
2021-12-01
Dec 1, 2021